Transmembrane protein 88 (TMEM88) is a transmembrane protein that plays a crucial role in regulating human stem cell differentiation and embryonic development. However, its expression and clinicopathologic significance in human neoplasms is unclear. In this study, the expression and subcellular localizations of TMEM88 were assessed in 214 cases of non-small cell lung cancer (NSCLC). Notably, TMEM88 was highly expressed in the cytosol of $60% NSCLC specimens examined. Higher expression of cytosolic TMEM88 in NSCLC correlated significantly with poor differentiation, high TNM stage, lymph node metastasis, and inferior survival. In NSCLC cells displaying membrane-localized TMEM88, we observed an inhibition of canonical Wnt signaling due to interactions of TMEM88 with the Wnt pathway factor Dishevelled (DVLS). In contrast, NSCLC cells with cytosol-localized TMEM88 lacked effects on Wnt signaling. Cytosolic interactions of TMEM88 and DVLS increased the expression of phosphorylated, active forms of p38, GSK3b (Thr390), and Snail, thereby reducing the expression of the tight junction-associated proteins ZO-1 and occludin, effects associated with enhanced invasive and metastatic cell characters. Importantly, attenuating the expression of cytosolic TMEM88 reduced metastatic prowess in xenograft models. Overall, our findings show how mislocalization of TMEM88 to the cytosol in NSCLC cells ablates its Wnt pathway regulatory properties, thereby promoting invasion and metastasis by activating the p38-GSK3b-Snail signaling pathway. Cancer Res; 75(21); 1-11. Ó2015 AACR.
Introduction
Transmembrane protein 88 (TMEM88) is a potential 2-transmembrane-type protein that interacts with the postsynaptic density 95/discs large/zonula occludens-1 (PDZ) domain of Dishevelled-1 (DVL-1), a crucial component of Wnt signaling (1) (2) (3) (4) (5) , through its C-terminal Val-Trp-Val (VWV) motif in Xenopus embryo cells (6) . TMEM88 has two isoforms: CRA-a (17 kDa) inhibits the canonical Wnt/b-catenin pathway by competing with low-density lipoprotein receptor-related proteins 5 and 6 to bind DVLS and regulates the development of myocardial cells, whereas CRA-b (25 kDa) lacks the VWV motif and may not interact with DVLS (7) . The current understanding of the expression, subcellular location, and potential molecular mechanisms of TMEM88 is limited, particularly for malignant human cells.
DVLS localize primarily to the cytoplasm and, to a lesser extent, the cell membrane (8) (9) (10) (11) . We previously demonstrated overexpression and primarily cytoplasmic localization of all three DVL family proteins (DVL-1, DVL-2, and DVL-3) in non-small cell lung cancer (NSCLC; ref. 11 ). This overexpression of DVLS enhanced P38 and JNK signaling and promoted proliferation and metastasis in NSCLC cells (12) . Because the biologic function of TMEM88 is dependent on DVL, we hypothesized that TMEM88 may also localize to the cytoplasm. Consistent with this hypothesis, our previous work revealed that TMEM88 localized to the cytoplasm in all human epithelial malignancies studied.
In this study, we aimed to define the roles played by cytosolic and membrane-bound TMEM88 in the Wnt signaling pathway and the relationship between subcellular localization and clinicopathologic factors. To this end, we investigated the biological function and mechanism of TMEM88 by controlling the expression of TMEM88 and/or DVLS in cell lines with intrinsic membrane-bound or cytosolic TMEM88.
Materials and Methods

Patients and specimens
This study was conducted with the approval of the Institutional Review Board at China Medical University. Primary lung cancer specimens were randomly obtained from 214 patients (141 males and 73 females). All patients underwent complete surgical resections in the First Affiliated Hospital of China Medical University between 2005 and 2014. Of the 214 lung cancer cases, 61 contained complete follow-up data. The survival of each patient was defined as the time from the day of surgery to the end of follow-up or the day of death due to recurrence or metastasis. None of the patients received radiotherapy or chemotherapy before surgical resection, and all patients received routine chemotherapy after surgery. The histologic diagnosis and grade were evaluated according to the 2004 WHO classification guidelines using hematoxylin and eosin-stained sections (13) . All 214 specimens of lung carcinoma were reevaluated for histologic subtype, differentiation, and tumor stage. Tumor staging was performed according to the seventh edition of the Union for International Cancer Control TNM Staging System for Lung Cancer (14) . The samples included 93 cases of squamous cell carcinoma and 121 cases of adenocarcinoma. Further, 51 tumors were highly differentiated, 83 were moderately differentiated, and 80 were poorly differentiated. Lymph node metastases were present in 131 cases and absent in 83 cases at the initial diagnoses. The patients were determined to be stage I to II in 111 cases and stage III in 103 cases.
For comparison with the immunohistochemical data, 40 fresh paired tumor and noncancerous tissue specimens were collected and immediately stored at À70 C for protein extraction and Western blot analysis (Supplementary Table S1 ). Furthermore, to determine the universality of TMEM88 expression patterns in epithelial malignant tumors, we collected specimens from 35 cases of colon carcinoma, 29 cases of breast carcinoma, 26 cases of hepatocellular carcinoma, and 24 cases of gastric carcinoma for immunohistochemical comparisons.
Cell lines
The HBE135-E6E7 (HBE) cell line was obtained from the American Type Culture Collection (Manassas, VA). The A549, H1299, H460, H292, SPC-A-1 (SPC), and LTEP-A-2 cell lines were obtained from Shanghai Cell Bank. The LK2 cell line was a gift from Dr. Hiroshi Kijima (Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki, Japan). The PG-BE1 and PG-LH7 cell lines were a gift from Dr. Jie Zheng (Department of Pathology, Peking University, Beijing, China). All cell lines were authenticated by short tandem repeat (STR) DNA profiling. Upon receipt, cells were frozen, and individual aliquots were cultured, typically for analysis within 10 passages. All cells were cultured in RPMI 1640 (Invitrogen) containing 10% fetal calf serum (Invitrogen), 100 IU/mL penicillin (Sigma), and 100 mg/mL streptomycin (Sigma).
Immunohistochemistry
Assays were performed as described previously (15) . Tissue sections were incubated with TMEM88 rabbit polyclonal antibody (1:50, Sigma). The intensity of TMEM88 staining was scored as follows: 0 (no staining), 1 (weak), 2 (moderate), or 3 (high). Percentage scores were assigned as follows: 1 (1%-25%), 2 (26%-50%), 3 (51%-75%), and 4 (76%-100%). The scores of each tumor sample were multiplied to give a final score of 0 to 12, and TMEM88 overexpression (positive expression) was defined for tumor samples with scores !4; tumor samples with scores between 1 and 4 were categorized as showing weak expression, whereas those with scores of 0 were considered to have negative expression.
Western blot analysis and immunoprecipitation
The assays were performed as described previously (15) . Detailed descriptions of antibodies are found in the Supplementary Materials and Methods.
Plasmid construction and transfection
Detailed descriptions of plasmids are found in the Supplementary Materials and Methods and Supplementary Table S2.
Immunofluorescence staining
Assays were performed as described previously (16) . The LK2, A549, H1299, and SPC cells were incubated overnight with an antibody against TMEM88 (1:50), DVL-1, DVL-2, DVL-3 (1:50), or Myc-tag (1:50), respectively. The subsequent assays were performed on A549 H1299, and SPC cells, where TMEM88 was localized primarily in the cytoplasm, and LK2 cells, where TMEM88 was localized on the cell membrane.
Dual-luciferase assay
Assays were performed as described previously (12) . Recombinant human Wnt3a (R&D Systems) was reconstituted at 10 mg/mL in phosphate-buffered saline containing 0.1% BSA, and used in experiments at a final concentration of 100 ng/mL.
RNA extraction and real-time RT-PCR
The assays were performed as described previously (15) . The sequences of the primers are listed in Supplementary Table S3 .
MTT
The assays were performed as described previously (17) .
Matrigel invasion and colony formation assays
The assays were performed as described previously (15) .
Wound healing assay
Wounds were made with a 200-mL pipette tip when the cultured cells reached a density of <90% confluence. The cells were washed to remove cell debris before subculturing in 2% serum culture medium. Wound healing within the scrape line was observed at different time points, and representative scrape lines for each cell line were photographed. Duplicate wells for each condition were examined for each experiment, and each experiment was repeated three times. The distance of the wound was optically measured using Image J software.
Transplantation of tumor cells into nude mice
The nude mice used in this study were treated following the experimental animal ethics guidelines issued at China Medical University. Four-week-old female BALB/c nude mice were purchased from Slac. Mice were kept in a laminar-flow cabinet under specific pathogen-free conditions for 2 weeks before use. Each mouse was inoculated subcutaneously in the axilla with 5 Â 10 6 tumor cells or the tail vein with 2 Â 10 6 tumor cells (TMEM88-transfected LK2, A549, and H1299 cells; TMEM88-shRNA-transfected SPC cells; or corresponding vector-transfected control cells) in 0.2 mL sterile phosphate-buffered saline. Six weeks after inoculation, the mice were sacrificed and autopsied to examine tumor growth and dissemination. In addition, the tumor mass, heart, liver, lung, and kidney were dissected. A portion of tissue from the tumor and each organ was fixed in 4% formaldehyde (Sigma) and embedded in paraffin. Serial 6-mm-thick sections were cut and stained with hematoxylin and eosin. The stained sections were examined microscopically.
Statistical analysis
All statistical analyses were performed using SPSS 17.0. The immunohistochemistry results were analyzed using the x 2 test and Spearman rank correlation. Kaplan-Meier survival analyses were carried out and compared using the log-rank test. The Cox regression model was used to test the prognostic value. All of the clinicopathologic parameters were included in the Cox regression model and tested by univariate analysis using the enter method and multivariate analysis using the forward stepwise logistic regression method. Differences between the groups were tested with a Student t test, and P < 0.05 was considered statistically significant.
Results
Cytosolic overexpression of TMEM88 correlates with poor NSCLC prognosis
Initially, we performed immunohistochemistry on 214 archived NSCLC specimens and the paired noncancerous (normal) tissues. TMEM88 was negatively or weakly expressed (<4; Fig. 1A -a and b) in normal tissue adjacent to the carcinoma: only 17.6% of the cases (12/68) showed positive expression at the membrane or in the cytosol (Fig. 1A-c Table  S4 ); however, there was no significant association with sex, age, or NSCLC histologic type. Kaplan-Meier survival analysis revealed that the overall survival for patients with cytosolic TMEM88 overexpression (38.8 AE 4.83 months) was significantly shorter than for those without (58.64 AE 4.24 months, P ¼ 0.008; Fig. 1B ). Cox univariate and multivariate analyses revealed that, along with lymph node metastasis, TNM stage and cytosolic overexpression of TMEM88 (P ¼ 0.024 and 0.025, respectively; Supplementary Table S5) could be considered independent prognostic factors in NSCLC.
We next evaluated the expression levels of TMEM88 isoforms in 40 fresh NSCLC samples using Western blot analysis. The normalized level of CRA-a in NSCLC tissues (mean AE SD: 0.86 AE 0.08) was significantly higher than in the paired noncancerous tissues (mean AE SD: 0.44 AE 0.06, P < 0.001; Fig. 1C ; Supplementary Fig. S1B) ; however, that of CRA-b, which lacks a DVL-binding motif (see Supplementary Fig. S1C ), was not significantly different between NSCLC tissues (mean AE SD: 0.86 AE 0.07) and paired noncancerous tissues (mean AE SD: 0.81 AE 0.06, P ¼ 0.6606; Supplementary Fig. S1D ). Therefore, we used CRA-a (hereafter referred to as TMEM88) for further studies. Expression and subcellular localization of TMEM88 in NSCLC tissue and cell lines. A, TMEM88 is negatively or weakly expressed in the paired normal bronchial (a, Â200) and alveolar epithelial cells (b, Â200), with occasional membrane-associated expression in focal areas (c, Â200 and inset, Â400). TMEM88 is highly expressed in the cytoplasm of lung cancer tissues (d, Â200, highly differentiated squamous carcinoma; e, Â200, moderately differentiated squamous carcinoma; f, Â200, poorly differentiated squamous carcinoma; g, Â200, highly differentiated adenocarcinoma; h, Â200, moderately differentiated adenocarcinoma; and i, Â200, poorly differentiated adenocarcinoma). B, Kaplan-Meier survival analysis demonstrates that the overall survival of patients with NSCLC and cytosolic overexpression of TMEM88 is significantly shorter than in those without cytosolic expression. C, Western blot analysis demonstrates that expression of the 17-kDa TMEM88 protein is significantly higher in the NSCLC tissues than that in the paired noncancerous tissues. D, Western blot analysis demonstrates that expression of 17-kDa TMEM88 in most NSCLC cell lines is higher than in normal bronchial epithelial cells (HBE) except for LK2 and H460 cells. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as an internal reference for normalization. E, immunofluorescence analysis of TMEM88-myc in A549, H1299 (TMEM88 localized in the cytoplasm), and LK2 (TMEM88 localized on the membrane) cells with a Myc-tag antibody. Overexpressed TMEM88 is localized primarily in the cytoplasm with additional nuclear expression in A549 and H1299 cells, whereas the overexpressed TMEM88 remains on the membrane in LK2 cells. No positive signal is detected in nontransfected cells; magnification, Â600. TMEM88 plays different roles in regulating the canonical Wnt pathway in cells with membrane-bound or cytosolic TMEM88. Transfection of TMEM88 inhibited the activity of the canonical Wnt signaling pathway in LK2 cells with membrane-localized TMEM88 (A; P ¼ 0.027 and 0.017) and decreased the protein (B) and mRNA (C; cyclin D1, P ¼ 0.014; MMP-7, P ¼ 0.012; and C-myc, P ¼ 0.006) expression of downstream target genes in the Wnt signaling pathway, including cyclin D1, MMP-7, C-myc, and active b-catenin. In contrast, transfection of TMEM88-DC increased the activity of the canonical Wnt signaling pathway (A; P ¼ 0.02 and 0.008), with no obvious effects on the expression levels of protein (B) and mRNA (C). In H1299 cells with cytosolic TMEM88 expression, neither TMEM88 nor TMEM88-DC showed inhibitory or activating effects on the canonical Wnt signaling pathway (D) or the expression of downstream target genes (E and F), and knocking down the expression of TMEM88 with siRNA in H1299 cells also showed no effect (G-I). Note the effects of TMEM88 on the canonical Wnt signaling pathway appear to be independent of treatment with Wnt3a (A, D, and G). Ã , P < 0.05; ÃÃ , P < 0.01.
We measured the expression of TMEM88 in breast cancer, colon carcinoma, hepatocellular carcinoma, and gastric carcinoma and confirmed that TMEM88 was generally overexpressed in cancer tissues compared with the corresponding noncancerous tissues (P ¼ 0.004, 0.007, 0.001, and 0.003, respectively; Supplementary Table S6 ). Moreover, TMEM88 expression was observed primarily in the cytoplasm, similar to the pattern observed for NSCLC, whereas membrane or nuclear expression was not detected in any of these additional cases ( Supplementary Fig.  S1E-a-h) .
To further confirm the expression of TMEM88 and its subcellular distribution, we performed Western blot and immunofluorescence analyses in nine NSCLC cell lines and a normal bronchial epithelial cell line (HBE). The expression of CRA-a in NSCLC cell lines (7/9) was significantly higher than in HBE cells (P < 0.05; Fig. 1D ) and was mainly localized in the cytoplasm (Supplementary Fig. S1F ). In contrast, TMEM88 expression was low in LK2 and H460 cells, and, notably, TMEM88 appeared primarily on the membrane in LK2 cells ( Fig. 1E; Supplementary Fig. S1F ). Interestingly, overexpressed myc-TMEM88 dominantly localized to the cytoplasm in A549 and H1299 cells with additional nuclear expression, whereas it remained on the cell membrane in LK2 cells (Fig. 1E ). These NSCLC cell lines provided a system for further exploration of the distinct biologic functions of TMEM88 associated with its unique distribution in different subcellular compartments.
TMEM88 inhibits the canonical Wnt signaling pathway in cells with membrane-associated TMEM88
We experimentally altered the expression of TMEM88 (Supplementary Fig. S2A ) and detected the effects on Wnt signaling and expression of downstream target genes. In cells with membrane-bound TMEM88 (LK2), overexpression of TMEM88 significantly inhibited the canonical Wnt signaling pathway (P ¼ 0.027; Fig. 2A ) through downregulation of downstream effectors, including cyclin D1, MMP-7, and C-myc (Fig. 2B and C) . In contrast, no inhibitory effect was observed for overexpression of TMEM88-DC, which has a mutated DVL binding site ( Fig. 2A-C) . To determine the effect in cells with cytosolic TMEM88, we transfected TMEM88 or TMEM88-DC into H1299 (Fig. 2D-F ) and A549 cells ( Supplementary Fig. S2B-S2D) , respectively, or knocked down endogenous TMEM88 with siRNA in H1299 (Fig.  2G-I ) and SPC ( Supplementary Fig. S2E-S2G ) cells. We observed no significant effect on the activity of the canonical Wnt signaling Figure 3 . Interaction between and colocalization of TMEM88 and DVLS. Transfected TMEM88 appeared primarily on the membrane in LK2 cells (A) or in the cytoplasm in H1299 cells (B), and both forms interacted with DVLS. Colocalization of TMEM88 and DVLS disappeared with transfection of TMEM88-DC in both cell lines (A and B; magnification, Â600. Coimmunoprecipitation performed with a Myc-tag antibody in LK2 and H1299 cells showed that TMEM88 interacts with DVL-1, DVL-2, and DVL-3 for both membrane and cytoplasmic distributions (C and D). The interaction with DVL-1 or with DVL-3 was stronger than with DVL-2, but all interactions were significantly decreased for TMEM88-DC.
pathway or the expression of downstream effectors for cell lines with cytosolic TMEM88.
These data suggest that TMEM88 suppresses the activity of the canonical Wnt signaling pathway in a DVL-dependent manner in cells with membrane-bound TMEM88, but it may not have such function in cells with cytosolic TMEM88.
TMEM88 interacts with DVLS in cells with membrane-bound and cytosolic TMEM88
We performed immunofluorescence and coimmunoprecipitation assays of myc-tagged TMEM88 or TMEM88-DC in cells with membrane-bound TMEM88 (LK2) or cytosolic TMEM88 (H1299). Immunofluorescent images indicated that TMEM88 interacted with both DVL-1 and DVL-3 on the cell membrane in LK2 cells ( Fig. 3A; Supplementary Fig. S3A ) and in the cytoplasm in H1299 cells ( Fig. 3B; Supplementary Fig. S3B ). Furthermore, we found that TMEM88 coimmunoprecipitated with DVL-1 and DVL-3 and, to a lesser extent, DVL-2 ( Fig. 3C and D ; Supplementary Fig. S3C ). In contrast, interaction between TMEM88-DC and DVL-1 or DVL-3 was significantly reduced, and we observed no colocalization on the membrane ( Fig. 3A and C; Supplementary Fig. S3A ) or in the cytoplasm ( Fig. 3B and D ; Supplementary Fig. S3B ). These results suggest that the C-terminus of TMEM88 is essential for interaction with DVLS. Similar experiments in SPC cells further showed that CRA-a interacted and colocalized with DVL-1, DVL-2, and DVL-3 ( Supplementary  Fig. S3D and S3E ) in the cytoplasm, whereas CRA-b did not ( Supplementary Fig. S3D ).
TMEM88 plays distinct roles in proliferation and invasion in cells with membrane-bound and cytosolic TMEM88
In LK2 cells with TMEM88 localized to the membrane, TMEM88 transfection significantly decreased proliferation (P ¼ 0.005; Fig. 4A ), colony formation (P ¼ 0.001; Fig. 4B ), migration (P < 0.001; Fig. 4C ), and invasion (P ¼ 0.007; Fig. 4D ). We subcutaneously injected TMEM88-transfected LK2 cells (LK2-TMEM88 þ ) or control cells into the axillae of nude mice. The average tumor volume (0.457 AE 0.174 cm 3 ) and weight (0.324 AE 0.094 g) in the LK2-TMEM88 þ group were significantly lower than in the control group (1.55 AE 0.24 cm 3 , P ¼ 0.002 and 0.831 AE 0.258 g, P ¼ 0.009, respectively; Fig. 4E-G) . In the group that received tail vein injections, the LK2-TMEM88 þ group had a lower lung metastatic rate (1/4) than the control group (2/4) and a significantly lower number of lung metastatic nodules (P ¼ 0.008; Fig. 4H-J) . Upregulation or downregulation of TMEM88 expression in cell lines with cytosolic TMEM88 (upregulation: H1299 and A549; downregulation: H1299 and SPC) showed no obvious changes in proliferation ( Fig. 4K; Supplementary Fig. S4A-S4C ) or colony formation ( Fig. 4L; Supplementary Fig. S4D-S4F ). However, increased or decreased TMEM88 enhanced or suppressed, respectively, migration (P < 0.001, Fig. 4M and P 0.001, Supplementary Fig. S4G-S4I ) and invasion (P ¼ 0.001, Fig. 4N and P ¼ 0.003, 0.035, and 0.018, respectively; Supplementary Fig. S4J-S4L) . Changes in TMEM88 expression in these cells did not affect the average xenograft tumor volume ( Fig. 4O-P; Supplementary Fig.  S5A and S5B, S5G and S5H) or weight ( Fig. 4Q ; Supplementary  Fig. S5C and S5I) . The lung metastatic rate (4/4 vs. 1/4 and 3/4 vs. 1/4, respectively) and the number of lung metastatic nodules in the mice transplanted with H1299-TMEM88 þ or A549-TMEM88 þ cells were significantly greater than in the control (P ¼ 0.009, Fig.  4R -T and P ¼ 0.04, Supplementary Fig. S5D-S5F ). The lung metastatic rate (1/4 vs. 4/4) and the number of lung metastatic nodules in the mice transplanted with SPC-TMEM88 (À) cells were significantly less than in the control (P ¼ 0.019; Supplementary  Fig. S5J-S5L ).
TMEM88-DVL downregulates occludin and ZO-1 by upregulating Snail
We hypothesized that cytosolic TMEM88 might affect cell invasion through the epithelial-mesenchymal transition. We overexpressed TMEM88 in H1299 and A549 cells and observed increased Snail protein without a significant change in transcript abundance ( Fig. 5A and B; Supplementary Fig. S6A and S6B) and decreased expressions of occludin and ZO-1 ( Fig. 5A and B ; Supplementary Fig. S6A and S6B) . Correspondingly, TMEM88 knockdown led to downregulation of Snail and upregulation of occludin and ZO-1 in H1299 and SPC cells ( Fig. 5A and B ; Supplementary Fig. S6A and S6B ). The expression levels of Ecadherin, N-cadherin, and vimentin were not significantly changed upon alteration of TMEM88 ( Supplementary Fig. S6C and S6D), and no morphological changes were observed (Supplementary Fig. S6E) .
Moreover, TMEM88-DC did not affect the expression of Snail, occludin, or ZO-1 (Fig. 5C) , and knockdown of DVLS markedly decreased the effect of overexpressed TMEM88 on Snail expression (Fig. 5D) . Compared with transfecting TMEM88 alone, cotransfection of TMEM88 with either DVL-1 or DVL-3 synergistically enhanced the expression of Snail with corresponding decreases in the levels of occludin and ZO-1 ( Supplementary Fig.  S7A ). Interestingly, cotransfection of TMEM88 with DVL-1 or DVL-3 also synergistically increased NSCLC cell invasion (Supplementary Fig. S7B and S7C ; invasive cells transfected with TMEM88þDVL-1 or TMEM88þDVL-3 vs. with TMEM88; P ¼ 0.006, P ¼ 0.007 in A549 and P ¼ 0.01, P ¼ 0.006 in H1299, respectively). Furthermore, downregulation of occludin and ZO-1 from cotransfection was abrogated by Snail-targeting siRNA (Supplementary Fig. S7D ). These data suggest that TMEM88 induces DVL-dependent Snail upregulation, which then mediates downregulation of occludin and ZO-1.
The increase in Snail protein but not mRNA suggests that TMEM88 either stabilizes Snail protein or increases its translation. Effects of TMEM88 on proliferation, migration, and invasion of cells with membrane-associated and cytosolic TMEM88. In LK2 cells with membrane-localized TMEM88, transfection of TMEM88 increased proliferation (A) and colony formation abilities (B) but inhibited migration (C, measured at 24 hours) and invasion (D).The average tumor volume (E and F) and weight (G) in mice subcutaneously injected with LK2-TMEM88 þ were significantly lower than in the control group, and mice injected with LK2-TMEM88 þ via the tail vein developed fewer pulmonary metastases than those in the control group (H-J; arrows, small metastases; Â40). In cells with cytosolic TMEM88 (H1299), transfection of TMEM88 showed no significant effect on proliferation (K) and colony formation (L) but enhanced migration (M) and invasion (N). The average tumor volume (O and P) and weight (Q) were not significantly different between mice subcutaneously injected with H1299-TMEM88 þ and control mice. Mice injected with H1299-TMEM88 þ developed more pulmonary metastases than those in the control group (R-T;
arrows, small metastases; Â40).
TMEM88-induced Snail expression synergistically increased upon addition of proteasome inhibitor MG132 (Fig. 5E) . These results suggest that interaction between TMEM88 and DVLS may stabilize Snail, thereby decreasing expression of occludin and ZO-1 and leading to increased invasiveness in NSCLC cell lines.
TMEM88 and DVLS synergistically upregulate Snail via phosphorylation of P38 and GSK3b
In addition to its effect on Snail, overexpression of TMEM88 increased the levels of phosphorylated P38 (p-P38), GSK3b (pGSK3b), and ATF2 (p-ATF2) (Supplementary Fig. S8A ). Addition of the P38 inhibitor SB203580 to the culture medium reduced levels of p-GSK3b (Thr390) and p-ATF2 and downregulated Snail expression (Fig. 6B) , indicating that p-P38 likely functions upstream of these factors. Correspondingly, NSCLC cell invasiveness decreased with P38 inhibition (Fig. 6C) . Cotransfection of TMEM88, DVLS, and GSK3b abolished the increase in Snail expression ( Supplementary Fig. S8C) ; however, Snail expression did not change when TMEM88-DC was transfected alone or with DVLS ( Supplementary Fig. S8D ). There were no significant changes in p-ERK, p-JNK, p-AKT, p-NF-kB (Ser536), or p-GSK3b (Ser9) levels ( Fig. 6A; Supplementary Fig. S8B ) or the nuclear/ cytoplasmic protein ( Supplementary Fig. S8E ) or mRNA (Supplementary Fig. S8F ) levels of NF-kB.
To analyze the correlation between TMEM88 and p-P38 or Snail, we performed immunohistochemical staining for the three proteins in 50 archived NSCLC specimens. Our results showed significant correlations in their expressions ( Supplementary Fig.  S8G and Supplementary Table S7, r ¼ 0.551, P < 0.001 for TMEM88 and p-P38; r ¼ 0.503, P ¼ 0.001, for TMEM88 and Snail).
Discussion
TMEM88 is a potential 2-transmembrane-typeprotein localized to the membrane in Xenopus embryo cells. Herein, we demonstrated that TMEM88 is highly expressed in a variety of epithelial malignancies, including NSCLC tissues and multiple . The additional decrease in Snail and increase in occludin in the group with only DVLS knockdown may arise from elimination of the activity of intrinsic TMEM88. E, cotransfection of TMEM88 and DVLS in H1299 cells had synergistic effects on the protein levels of Snail, occludin, and ZO-1 (lanes 5 and 6) compared with isolated transfection of TMEM88 (lane 2), DVL-1 (lane 3), or DVL-3 (lane 4). These effects were further enhanced when proteasome inhibitor (10 mmol/L MG132) was added to the culture medium, with the greatest effect seen for cotransfections (lanes 11 and 12).
lung cancer cell lines, and primarily localizes to the cytoplasm. The cytosolic expression of TMEM88 directly correlated with low differentiation, high TNM stage, lymph node metastasis, and poor prognosis. We further identified membrane-localized TMEM88 in a few NSCLC specimens and one lung cancer cell line (LK2), but this expression pattern was not detected in other epithelial malignancies. These results suggest that the expression and subcellular localization of TMEM88 may be species dependent, which remains to be investigated in future studies.
Furthermore, we found that TMEM88 played distinct roles in cells with membrane-associated or cytosolic TMEM88. It inhibited the proliferation, migration, and invasiveness of LK2 cells with membrane-associated TMEM88, whereas TMEM88 enhanced migration and invasion but did not affect proliferation in cells with cytosolic expression (H1299, A549, and SPC cells).
Cell lines with membrane-associated TMEM88 showed colocalization with DVLS and DVL interaction-dependent inhibition of the canonical Wnt signaling pathway activity and downstream target gene expression (Fig. 7) . These results are consistent with observations in Xenopus embryo cells (6) . Our results further show that TMEM88 interacts with DVLS in the cytoplasm (e.g., in H1299 cells) with no obvious effects on Wnt signaling activity or downstream gene expression; instead, cytosolic TMEM88 upregulated Snail in a DVL-dependent manner. Snail upregulation decreased occludin and ZO-1 expression, thereby enhancing the invasion and metastasis of lung cancer cells (Fig. 7) . We observed no effect on Snail, occludin, or ZO-1 expression in cell lines with membrane-associated TMEM88 (Supplementary Fig. S9 ).
Our results demonstrated that TMEM88 increases the level of Snail protein by interacting with DVLS but does not affect its mRNA expression. We screened for key factors in the signaling pathway (e.g., MAPK and AKT; refs. 18-23) and crucial proteins (GSK3b and NF-kB; refs. 24-29) affecting Snail stabilization. Our results suggest that the interaction between TMEM88 and DVLS increases p-P38 and p-GSK3b (Thr390) levels, which upregulates Snail. These results are consistent with our previous finding that DVL upregulates p-P38 and previous reports that P38 activation may promote phosphorylation of GSK3b (Thr390), which inactivates GSK3b (30) and consequently stabilizes Snail (25) (26) 31) .
The factors influencing differential TMEM88 subcellular localization in different lung cancer cell lines are unknown. TMEM88 contains two transmembrane regions, and mutation Figure 6 . Effects of cotransfection of TMEM88 and DVLS on proteins involved in Snail stabilization. A, the expressions of p-ERK, p-JNK, p-AKT, p-GSKb (Ser9), and p-NF-kB (Ser536) showed no significant changes upon cotransfection of TMEM88 and DVLS in H1299 cells. When a P38 inhibitor (10 mmol/L SB203580) was added to the culture medium, the effects of cotransfection on the expression of p-ATF2 and p-GSK3b (Thr390) were diminished or abolished, and there was a corresponding decrease in Snail, increase in occludin and ZO-1 (B), and increased invasion in H1299 cells (C).
or posttranslational modification in these regions might alter its membrane localization. In addition, any problems during transport to the membrane might affect membrane localization, and molecules affecting its membrane anchor might further influence this process. To date, the DVL is known to interact only with TMEM88, and whether novel interaction partners restrict its membrane localization is not clear. Therefore, indepth investigation to compare gene and protein expression levels for cells with membrane-associated or cytosolic TMEM88 and identify TMEM88-interacting proteins is needed.
Jang and colleagues previously demonstrated that miR708 suppresses transcription of TMEM88, thus promoting the invasion of NSCLC cells (H1299; ref. 32). However, this study did not report the expression level of the TMEM88 protein, and it is therefore unclear whether the enhanced invasion of NSCLC cells was due to suppression of TMEM88 transcription or some other mechanism. Moreover, conflicting reports have suggested that miR708 suppresses migration and invasion of tumor cells (33) (34) (35) .
In conclusion, we have demonstrated that TMEM88 is highly expressed and primarily localized to the cytoplasm in most cancer tissues and lung cancer cell lines studied herein. Its cytosolic localization is correlated with low differentiation, high TNM stage, lymph node metastasis, and poor prognosis in NSCLC. In cells with membrane-bound TMEM88, TMEM88 might recruit DVLS to the membrane and inhibit the canonical Wnt signaling pathway, leading to decreased proliferation and invasion of NSCLC cells. In contrast, in cells with cytosolic TMEM88, the cytosolic TMEM88-DVL complex may facilitate phosphorylation of P38 and GSK3b, thereby stabilizing Snail and leading to downregulation of occludin and ZO-1, which ultimately results in an enhanced migration and invasion of NSCLC cells.
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